CD200R1 and CD200 expression are regulated by PPAR‐γ in activated glial cells
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The mechanisms that control microglial activation are of interest, since neuroinflammation, which involves reactive microglia, may be an additional target in the search for therapeutic strategies to treat neurodegenerative diseases. Neuron‐microglia interaction through contact‐dependent or independent mechanisms is involved in the regulation of the microglial phenotype in both physiological and pathological conditions. The interaction between CD200, which is mainly present in neurons but also in astrocytes, and CD200R1, which is mainly present in microglia, is one of the mechanisms involved in keeping the microglial proinflammatory phenotype under control in physiological conditions. Alterations in the expression of CD200 and CD200R1 have been described in neurodegenerative diseases, but little is known about the mechanism of regulation of these proteins under physiological or pathological conditions. The aim of this work was to study the modulation of CD200 and CD200R1 expression by peroxisome proliferator‐activated receptor gamma (PPAR‐γ), a transcription factor involved in the control of the inflammatory response. Mouse primary neuronal and glial cultures and neuron‐microglia cocultures were treated with the PPAR‐γ endogenous ligand 15‐deoxy‐Δ 12, 14‐prostaglandin J 2 (15d‐PGJ 2) in the presence and absence of lipopolysaccharide plus interferon‐γ (LPS/IFN‐γ)‐induced glial activation. We show that 15d‐PGJ 2 inhibits the pro‐inflammatory response and prevents both CD200R1 downregulation and CD200 upregulation in reactive glial cells. In addition, 15d‐PGJ 2 abrogates reactive‐microglia induced neurotoxicity in neuron‐microglia cultures through a CD200‐CD200R1 dependent mechanism. These results suggest that PPAR‐γ modulates CD200 and CD200R1 gene expression and that CD200‐CD200R1 interaction is involved in the anti‐inflammatory and neuroprotective action of PPAR‐γ agonists. GLIA 2014;62:982–998
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
The myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804
Leesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E., Collins, J. L., Consler, T. G., Davis, R. G., Hull-Ryde, E. A., Lenhard, J. M., Patel, L., et al. (2002) · Biochemistry · doi:10.1021/bi0159581 · Cited by 616 · cited 2×
“…glial cells is mainly mediated by its interaction with PPAR-c because it is abrogated by the PPAR-c antagonists GW9662 and BADGE, which act on the ligand-binding domain of PPAR-c and pre- vent ligand-dependent activation of the nuclear receptor (Leesnitzer et al., 2002; Wright et al., 2000a).”
BackgroundHeneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Kapadia, R. (2008) · Frontiers in Bioscience · doi:10.2741/2802 · Cited by 433 · cited 2×
“Peroxisome proliferator-activated receptor-gamma (PPAR-c) transcription factor activation plays a role in controlling the inflammatory response by inhibiting the expression of proinflammatory factors, and PPAR-c agonists have been found to have anti-inflammatory and neuroprotective properties (Kapadia et al., 2009).”
BackgroundLyons, A., Downer, E. J., Crotty, S., Nolan, Y. M., Mills, K. H. G., & Lynch, M. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1781-07.2007 · Cited by 258 · cited 4×
“Positive regulation of murine neuronal CD200 expression by the anti-inflammatory cytokines IL-4 and IL-10 has also been described (Hernang omez et al., 2012; Lyons et al., 2007).”
BackgroundInfluentialBernardo, A., Levi, G., & Minghetti, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00110.x · Cited by 222 · cited 2×
“…15d-PGJ2 in activated primary microglial and astroglial cells in vitro, such as inhibition of NO and pro-inflammatory cytokines and chemokines production, and inhibition of iNOS expression (Bernardo et al., 2000; Giri et al., 2004; Gurley et al., 2008; Storer et al., 2005; Xu and Drew, 2007).”
BackgroundPark, E. J., Park, S. Y., Joe, E.-H., & Jou, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210819200 · Cited by 214 · cited 2×
“, 2008) or induction of the suppressor of cytokine signalling 1 and 3 (Park et al., 2003).”
BackgroundZhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154 · cited 2×
“, 2012) and the inhibition of CD200R1 function potentiates it (Lyons et al., 2007; Wang et al., 2011; Zhang et al., 2011), suggesting that CD200-CD200R1 interaction is involved in the suppression of the pro-inflammatory phenotype in microglia.”
BackgroundWang, X.-J., Zhang, S., Yan, Z.-Q., Zhao, Y.-X., Zhou, H.-Y., Wang, Y., Lu, G.-Q., & Zhang, J.-D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.032 · Cited by 108
Cited by
Alternatively activated microglia and macrophages in the central nervous system
Franco, R., & Fernández-Suárez, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.003 · Cited by 650
Neuroinflammation in the central nervous system: Symphony of glial cells
Yang, Q., & Zhou, J. (2019) · Glia · doi:10.1002/glia.23571 · Cited by 519
Bidirectional Microglia–Neuron Communication in Health and Disease
Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459
“…peroxisome proliferator-activated receptor gamma (PPAR-γ), which is a transcription factor controlling the inflammatory response, has been reported to regulate CD200 and CD200R1 gene expression, which could be related to the neuroprotective action of PPARγ agonists (Dentesano et al., 2014).”
BackgroundTargeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
Subramaniam, S. R., & Federoff, H. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00176 · Cited by 347
Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., & Zhang, H.-L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0245-0 · Cited by 262
Metadata
- Authors
- Dentesano, G., Serratosa, J., Tusell, J. M., Ramón, P., Valente, T., Saura, J., & Solà, C.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2014-03-17
- Volume
- 62
- Issue
- 6
- Pages
- 982-998
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W1910163729
- Cited by
- 58
- References
- 10
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.